Eastman Chemical CO Form 4 insider transactions
NYSE
Eastman Chemical's Controller and CAO, Michelle Renee Stewart, received grants of stock options and restricted stock units.
NYSE
Julie A. McAlindon, SVP at Eastman Chemical Co., received grants of 24,364 stock options and 3,352 restricted stock units.
NYSE
Eastman Chemical CEO Mark J. Costa received significant equity awards, including stock options and restricted stock units, on February 24, 2026.
NYSE
Eastman Chemical's EVP, Brian Travis Smith, received new equity awards, including 53,157 employee stock options and 7,313 restricted stock units.
NYSE
Eastman Chemical's SVP and Chief Manufacturing Officer, Michelle H. Caveness, received significant equity awards including stock options and restricted stock units.
NYSE
Eastman Chemical's SVP, CLO & Corporate Secretary, Bosede Ikeolu Gbadegesin, received new employee stock options and restricted stock units on February 24, 2026.
NYSE
Eastman Chemical's EVP & CCO, Brad A. Lich, was granted 63,123 employee stock options and 8,684 restricted stock units on February 24, 2026.
NYSE
Eastman Chemical Co.'s EVP and CFO, William Thomas McLain Jr., acquired 59,801 employee stock options and 8,227 restricted stock units.
NYSE
Eastman Chemical's EVP & CCO, Brad A. Lich, reported the future acquisition of 18,861 common shares as performance awards for the 2023-2025 period.
NYSE
Eastman Chemical's EVP and CFO, William Thomas McLain Jr., acquired 15,883 shares of common stock through the vesting of performance shares.
NYSE
Eastman Chemical's Controller and CAO, Michelle Renee Stewart, acquired 3,309 shares of common stock as performance shares for the 2023-2025 period.
NYSE
Eastman Chemical's SVP, Julie A. McAlindon, acquired 7,280 shares of common stock as performance-based compensation for the 2023-2025 period.
NYSE
Eastman Chemical Co.'s SVP & Chief Manufacturing Officer, Michelle H. Caveness, acquired 1,937 shares of common stock as performance shares.
NYSE
Eastman Chemical's EVP, Brian Travis Smith, acquired 10,589 shares of common stock as part of performance share determination.
NYSE
Adrian James Holt, SVP and Chief HR Officer at Eastman Chemical Co., received 2,297 shares of common stock as performance-based compensation.
NYSE
Eastman Chemical CEO Mark J. Costa exercised stock options, acquiring shares and simultaneously disposing of a portion for tax and exercise costs.
NYSE
Eastman Chemical's EVP and CFO, William Thomas McLain Jr., exercised stock options, resulting in a net increase of 377 shares in his direct beneficial ownership.
NYSE
Eastman Chemical's EVP of Technology Projects, Stephen G. Crawford, was granted 34,193 restricted stock units vesting in February 2027.
NYSE
Eastman Chemical Director Damon J. Audia increased his beneficial ownership of phantom stock units through deferred compensation.
NYSE
Eastman Chemical Co. Director Renee J. Hornbaker acquired 487 phantom stock units through an automatic deferral of annual retainer fees.
NYSE
Eastman Chemical Company Director Linnie M. Haynesworth acquired 487 phantom stock units through an automatic deferral of annual retainer fees.
NYSE
Eastman Chemical Co. Director Eric L. Butler acquired 487 phantom stock units through an automatic deferral of annual retainer fees.
NYSE
Eastman Chemical Company director Julie Fasone Holder acquired 487 phantom stock units through a deferred compensation plan, increasing her total beneficial ownership to 14,377 units.
NYSE
Director James J. O'Brien acquired 487 phantom stock units of Eastman Chemical through a deferral of director's fees.
NYSE
Eastman Chemical Director Donald W. Slager deferred a portion of his annual retainer fees into 487 phantom stock units, increasing his total beneficial ownership to 1,267 units.
NYSE
Eastman Chemical Co. Director Brett D. Begemann increased his beneficial ownership of phantom stock units through voluntary and automatic fee deferrals.
NYSE
Eastman Chemical Director Kim Ann Mink increased her beneficial ownership of phantom stock units through an automatic deferral of fees.
NYSE
Eastman Chemical Co. Director Humberto P. Alfonso increased his beneficial ownership of phantom stock units through deferral of director fees.
NYSE
Eastman Chemical's SVP & Chief Manufacturing Officer, Michelle H. Caveness, reported the vesting of restricted stock units and subsequent tax withholding.
NYSE
Eastman Chemical's SVP, Chief HR Officer, Adrian James Holt, acquired 2,200 phantom stock units under an executive deferred compensation plan.